Diquafosol ophthalmic solution for dry eye treatment

Nakamura M., Imanaka T., Sakamoto A.

2012
Advances in Therapy

View publication

Therapeutic Area

Front of the eye (FOTE)
Technology

Pharmacology
Categories

Clinical development

Affiliations

Research and Development Division, Santen Pharmaceutical Co., Ltd, 8916-16, Takayama-cho, Ikoma-shi, Nara 630-0101., Japan; Research and Development Division, Santen Pharmaceutical Co., Ltd., 3-9-19, Shimoshinjo, Higashiyodogawa-ku, Osaka 533-8651, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022